1. Home
  2. WVVI vs VYNE Comparison

WVVI vs VYNE Comparison

Compare WVVI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willamette Valley Vineyards Inc.

WVVI

Willamette Valley Vineyards Inc.

HOLD

Current Price

$2.91

Market Cap

13.0M

ML Signal

HOLD

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVVI
VYNE
Founded
1983
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0M
12.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WVVI
VYNE
Price
$2.91
$0.41
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7K
892.9K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,366,837.00
$524,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.29
52 Week Low
$2.49
$0.28
52 Week High
$7.18
$4.30

Technical Indicators

Market Signals
Indicator
WVVI
VYNE
Relative Strength Index (RSI) 51.28 61.95
Support Level $2.71 $0.37
Resistance Level $3.00 $0.39
Average True Range (ATR) 0.15 0.03
MACD 0.07 0.00
Stochastic Oscillator 88.00 87.95

Price Performance

Historical Comparison
WVVI
VYNE

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: